STE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $208.54

Market Cap (MRQ) $20.33B

P/E 26.3

EPS $7.93

Revenue $5.94B

Div Yield 1.2%

ROE 11.3%

Debt/Equity (MRQ) 0.3

52W Range $195–$269

STE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 2

Ex-date	Split	Type
Aug. 25, 1998	2-for-1	Forward
Aug. 25, 1995	2-for-1	Forward

About STERIS plc (Ireland) Ordinary Shares Company overview from Wikipedia

05 · wikidata

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

Steris is listed on the New York Stock Exchange, and is a constituent of the S&P 500 Index. As of 2024, the president and CEO is Daniel A. Carestio.

## History

Steris was founded in August 1985 in Ohio, under the name "Innovative Medical Technologies".

In 2012, Steris acquired US Endoscopy for $270 million. Steris also acquired Spectrum Surgical Instruments Corp. and Total Repair Express for $110 million combined.

On April 1, 2014, Steris announced its acquisition of Integrated Medical Systems International Inc. for ~$175 million, although it would only cost the company ~$140 million after tax benefits. Shortly after, Steris also acquired Chesterfield, Missouri-based Life Systems.

In October 2014, Steris executed a tax inversion from the United States to the United Kingdom, via an offer made to acquire UK-based Synergy Health for $1.9 billion. The tax inversion was notable as it was the first US inversion post the new rules introduced by the Obama administration in 2014 to curb US corporations moving their "legal domicile" to reduce their exposure to US corporate taxation.

On June 24, 2015, Steris announced the acquisitions of General Econopak for $175 million and Black Diamond Video for $51 million.

Steris filed accounts which showed global revenues of over US$2.6 billion in 2018, of which US$1.8 billion (or 70 percent) came from the US healthcare system; and employed ~12,000 people.

In November 2018, Steris announced that it would further re-domicile its legal headquarters from the United Kingdom to Ireland; Steris had reduced its corporate tax rate from 31.3 percent to 20 percent as a result of its 2014 tax inversion to the United Kingdom, however, it believed a further reduction could be achieved by moving to Ireland.

In April 2020, Steris received emergency use authorization from the FDA for a N95 mask sterilization system to help address the shortage of personal protective equipment during the 2019-20 coronavirus pandemic.

In November 2020, Steris acquired Key Surgical, a leading global provider of sterile processing, operating room, and endoscopy products.

In June 2021, Steris acquired Cantel Medical Corporation a provider of infection prevention products and services to endoscopy, dental and dialysis.

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$5.94B

2017-03-31 → 2026-03-31

EPS$7.93

2017-03-31 → 2026-03-31

Free Cash Flow$972M

2019-03-31 → 2026-03-31

Net margin13.3%

2019-03-31 → 2026-03-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	STE	5Y avg	Peer Median	Verdict
P/E	26.35Y avg ≈79.9	≈79.9	·	·
P/S (TTM)	3.45Y avg ≈4.4	≈4.4	·	·
P/B (MRQ)	2.85Y avg ≈3.3	≈3.3	·	·
Price / FCF (TTM)	22.05Y avg ≈39.2	≈39.2	·	·
Price / Cash Flow (TTM)	15.85Y avg ≈23.7	≈23.7	·	·
Price / Tangible Book (MRQ)	3.65Y avg ≈100.9	≈100.9	·	·
PEG Ratio	≈2.3	·	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	STE	5Y avg	Peer Median	Verdict
Gross Margin (TTM)	44.4%5Y avg ≈43.8%	≈43.8%	·	·
Operating Margin (TTM)	18.9%5Y avg ≈13.1%	≈13.1%	·	·
EBITDA Margin (TTM)	27.0%5Y avg ≈23.3%	≈23.3%	·	·
Pretax Margin (TTM)	18.0%5Y avg ≈11.2%	≈11.2%	·	·
Net Profit Margin (TTM)	13.3%5Y avg ≈7.9%	≈7.9%	·	·
ROA	7.5%5Y avg ≈4.1%	≈4.1%	·	·
ROE	11.3%5Y avg ≈6.7%	≈6.7%	·	·
ROIC	9.1%5Y avg ≈5.8%	≈5.8%	·	·

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	STE	5Y avg	Peer Median	Verdict
Debt / Equity (MRQ)	0.35Y avg ≈0.4	≈0.4	·	·
Current Ratio (MRQ)	1.95Y avg ≈2.3	≈2.3	·	·
Quick Ratio	1.05Y avg ≈1.0	≈1.0	·	·
Long-Term Debt / Equity (MRQ)	0.25Y avg ≈0.4	≈0.4	·	·

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	STE	5Y avg	Peer Median	Verdict
Revenue YoY	8.7%5Y avg ≈14.3%	≈14.3%	·	·
Revenue CAGR 3Y	9.4%5Y avg ≈12.2%	≈12.2%	·	·
Revenue CAGR 5Y	13.8%	·	·	·
EPS YoY	27.9%5Y avg ≈48.7%	≈48.7%	·	·
Net Income YoY	27.3%5Y avg ≈49.7%	≈49.7%	·	·
EPS CAGR 3Y	95.0%5Y avg ≈41.5%	≈41.5%	·	·
EPS CAGR 5Y	11.4%	·	·	·
Net Income CAGR 3Y	94.1%5Y avg ≈42.8%	≈42.8%	·	·
Net Income CAGR 5Y	14.5%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	STE	5Y avg	Peer Median	Verdict
EPS (Diluted)	$7.935Y avg ≈$4.30	≈$4.30	·	·
Revenue / Share	$60.145Y avg ≈$52.61	≈$52.61	·	·
Cash Flow / Share	$13.595Y avg ≈$9.90	≈$9.90	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	STE	5Y avg	Peer Median	Verdict
Asset Turnover	0.65Y avg ≈0.5	≈0.5	·	·
Inventory Turnover	5.55Y avg ≈5.0	≈5.0	·	·
Receivables Turnover	5.65Y avg ≈5.7	≈5.7	·	·
Revenue / Employee	≈$330.9K	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

13

Dividend Yield1.2%

Payout Ratio30.9%

Annualized Payout≈$2.76Paid quarterly

5Y Div CAGR≈8.2%Per share, split-adjusted

Growth Streak≈19Consecutive years of dividend growth

Ex-date	Amount	Currency	Yield
Sep 4, 2026	$0.69	USD	≈0.87%
Jun 8, 2026	$0.63	USD	≈0.90%
Feb 17, 2026	$0.63	USD	≈0.75%
Sep 4, 2025	$0.63	USD	≈0.96%
Jun 10, 2025	$0.57	USD	≈0.94%
Feb 20, 2025	$0.57	USD	≈1.0%
Nov 19, 2024	$0.57	USD	≈1.0%
Sep 5, 2024	$0.57	USD	≈0.89%
Jun 12, 2024	$0.52	USD	≈0.92%
Feb 22, 2024	$0.52	USD	≈0.86%
Nov 20, 2023	$0.52	USD	≈0.99%
Sep 5, 2023	$0.52	USD	≈0.86%
Jun 13, 2023	$0.47	USD	≈0.91%
Feb 23, 2023	$0.47	USD	≈0.98%
Nov 21, 2022	$0.47	USD	≈1.0%
Sep 6, 2022	$0.47	USD	≈0.89%
Jun 13, 2022	$0.43	USD	≈0.81%
Feb 24, 2022	$0.43	USD	≈0.74%
Nov 22, 2021	$0.43	USD	≈0.72%
Sep 2, 2021	$0.43	USD	≈0.75%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 1.8%

Next Report Nov 03, 2026

Period	EPS Actual	EPS Est	Surprise
June 30, 2026	$2.59	$2.53	2.5%
March 31, 2026	$2.83	$2.88	-1.6%
Dec. 31, 2025	$2.53	$2.56	-1.1%
Sept. 30, 2025	$2.47	$2.37	4.0%
June 30, 2025	$2.34	$2.29	2.4%
March 31, 2025	$2.74	$2.62	4.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 17

Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$5.94B	$5.46B	$5.14B	$4.54B	$4.22B	$3.11B	$3.03B	$2.78B	$2.62B	$2.61B
Cost of Revenue	$3.31B	$3.06B	$2.92B	$2.56B	$2.34B	$1.76B	$1.71B	$1.61B	$1.53B	$1.59B
Gross Profit	$2.63B	$2.40B	$2.22B	$1.98B	$1.88B	$1.34B	$1.32B	$1.17B	$1.09B	$1.03B
R&D Expense	$113M	$108M	$104M	$98M	$87M	$66M	$66M	$63M	$61M	$59M
SG&A Expense	$1.41B	$1.33B	$1.25B	$1.09B	$1.32B	$731M	$717M	$670M	$632M	$682M
Operating Expenses	$1.52B	$1.54B	$1.38B	$1.19B	$1.41B	$795M	$783M	$764M	$693M	$800M
Operating Income	$1.10B	$867M	$836M	$791M	$478M	$548M	$537M	$411M	$400M	$226M
Interest Expense	·	·	$144M	$108M	$89M	$37M	$40M	$45M	$51M	$45M
Other Non-op	$10M	$8M	$11M	$-3M	$6M	$6M	$2M	$3M	$6M	$3M
Pretax Income	$1.05B	$796M	$703M	$680M	$367M	$518M	$499M	$369M	$355M	$185M
Income Tax	$262M	$185M	$150M	$124M	$82M	$121M	$91M	$64M	$63M	$74M
Net Income	$782M	$615M	$378M	$107M	$244M	$397M	$408M	$304M	$291M	$110M
EPS (Basic)	$7.97	$6.24	$3.83	$1.07	$2.50	$4.66	$4.81	$3.59	$3.42	$1.29
EPS (Diluted)	$7.93	$6.20	$3.81	$1.07	$2.48	$4.63	$4.76	$3.55	$3.39	$1.28
Shares (Basic)	98,200,000	98,600,000	98,800,000	99,706,000	97,535,000	85,203,000	84,778,000	84,577,000	85,028,000	85,473,000
Shares (Diluted)	98,700,000	99,100,000	99,400,000	100,246,000	98,326,000	85,898,000	85,641,000	85,468,000	85,713,000	86,094,000
EBITDA	$1.59B	$1.34B	$1.40B	$821M	$979M	$768M	$734M	$637M	·	·

Balance Sheet 27

Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$440M	$172M	$207M	$208M	$348M	$221M	$320M	$221M	$202M	$283M
Receivables	$1.09B	$1.04B	$1.01B	$865M	$799M	$609M	$586M	$565M	$528M	·
Inventory	$632M	$581M	$675M	$604M	$575M	$315M	$264M	$208M	$206M	·
Current Assets	$2.39B	$2.00B	$2.87B	$2.01B	$1.88B	$1.21B	$1.22B	$1.05B	$990M	·
PP&E (Net)	$2.16B	$1.96B	$1.77B	$1.63B	$1.55B	$1.24B	$1.11B	$1.03B	$1.01B	·
PP&E (Gross)	$4.11B	$3.69B	$3.34B	$3.05B	$2.82B	$2.39B	$2.13B	$1.99B	$1.85B	·
Accum. Depreciation	$1.94B	$1.73B	$1.57B	$1.41B	$1.27B	$1.15B	$1.02B	$956M	$841M	·
Goodwill	$4.19B	$4.10B	$4.07B	$3.88B	$3.94B	$3.03B	$2.36B	$2.32B	$2.43B	$2.23B
Intangibles	$1.62B	$1.85B	$2.12B	$2.08B	$3.33B	$898M	$565M	$605M	$727M	·
Other Non-current Assets	$211M	$83M	$66M	$78M	$71M	$53M	$52M	$60M	$39M	·
Total Assets	$10.74B	$10.15B	$11.06B	$10.82B	$11.42B	$6.57B	$5.44B	$5.07B	$5.20B	·
Accounts Payable	$339M	$281M	$252M	$264M	$226M	$157M	$149M	$153M	$136M	·
Accrued Liabilities	$402M	$368M	$320M	$298M	$307M	$221M	$192M	$188M	$168M	·
Short-term Debt	$119M	$125M	$86M	$60M	$143M	$0	$0	·	·	·
Current Liabilities	$1.15B	$1.02B	$931M	$862M	$922M	$578M	$504M	$465M	$398M	·
Capital Leases	$120M	$125M	$146M	$140M	$155M	$130M	$114M	$0	·	·
Deferred Tax	·	·	·	·	·	·	·	$151M	$160M	·
Other Non-current Liabilities	$72M	$62M	$72M	$76M	$76M	$88M	$90M	$88M	$109M	·
Total Liabilities	$3.54B	$3.53B	$4.75B	$4.73B	$4.88B	$2.68B	$2.02B	$1.89B	$1.98B	·
Long-term Debt	$1.81B	$1.92B	$3.12B	$3.02B	$2.95B	$1.65B	$1.15B	$1.18B	$1.32B	·
Total Debt	$1.93B	$2.04B	$3.21B	$3.08B	$3.09B	$1.65B	$1.15B	$1.18B	·	·
Common Stock	$4.28B	$4.42B	$4.54B	$4.49B	$4.74B	$2.00B	$1.98B	$2.00B	$2.05B	·
Retained Earnings	$3.02B	$2.48B	$2.09B	$1.91B	$2.00B	$1.94B	$1.66B	$1.34B	$1.15B	·
AOCI	$-113M	$-292M	$-329M	$-321M	$-210M	$-61M	$-235M	$-160M	$12M	$-241M
Stockholders' Equity	$7.18B	$6.60B	$6.30B	$6.08B	$6.53B	$3.88B	$3.41B	$3.18B	$3.21B	·
Liabilities + Equity	$10.74B	$10.15B	$11.06B	$10.82B	$11.42B	$6.57B	$5.44B	$5.07B	$5.20B	·
Shares Outstanding	97,800,000	98,300,000	98,900,000	98,600,000	100,067,000	85,353,000	84,924,000	84,517,000	84,747,000	·

Cash Flow 18

Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$486M	$476M	$565M	$553M	$553M	$219M	$197M	$226M	$178M	$188M
Stock-based Comp	$62M	$57M	$56M	$39M	$58M	$26M	$24M	$24M	$22M	$19M
Deferred Tax	$-17M	$-76M	$-131M	$-186M	$-107M	$4M	$9M	$-7M	$-25M	$31M
Amort. of Intangibles	$268M	$276M	$268M	$260M	$265M	$87M	$75M	$99M	$70M	$69M
Restructuring	$3M	$62M	$44M	$485.0K	$48.0K	$-3M	$3M	$41M	$103.0K	$215.0K
Other Non-cash	$28M	$76M	$105M	$244M	$-63M	$43M	$-48M	$-8M	·	·
Operating Cash Flow	$1.34B	$1.15B	$973M	$757M	$685M	$690M	$591M	$540M	$458M	$424M
CapEx	$369M	$370M	$360M	$362M	$288M	$239M	$215M	$190M	$165M	$173M
Investing Cash Flow	$-512M	$389M	$-887M	$-383M	$-667M	$-1.15B	$-320M	$-213M	$-204M	$-104M
Net Debt Issued	·	·	·	·	·	$-35M	$0	$-85M	·	·
Stock Repurchased	$236M	$211M	$12M	$309M	$56M	$15M	$51M	$81M	$65M	$98M
Net Stock Activity	$-236M	$-211M	$-12M	$-309M	$-56M	$-15M	$-51M	$-81M	·	·
Dividends Paid	$242M	$220M	$201M	$183M	$163M	$134M	$123M	$113M	$103M	$93M
Financing Cash Flow	$-568M	$-1.57B	$-85M	$-499M	$116M	$346M	$-163M	$-295M	$-356M	$-267M
Net Change in Cash	$268M	$-35M	$-1M	$-140M	$128M	$-99M	$99M	$19M	$-81M	$34M
Taxes Paid	$289M	$274M	$271M	$255M	$138M	$110M	$92M	$65M	$86M	$78M
Free Cash Flow	$972M	$778M	$613M	$395M	$397M	$450M	$376M	$350M	·	·
Levered FCF	·	·	$499M	$322M	$328M	$422M	$343M	$313M	·	·

Profitability 8

Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
Gross Margin	44.2%	44.0%	43.2%	43.6%	44.0%	43.2%	43.5%	42.2%	·	·
Operating Margin	18.6%	15.9%	16.3%	5.4%	9.3%	17.6%	17.7%	14.8%	·	·
Net Margin	13.2%	11.3%	7.4%	2.2%	5.3%	12.8%	13.5%	10.9%	·	·
Pretax Margin	17.6%	14.6%	13.7%	3.2%	6.9%	16.7%	16.4%	13.3%	·	·
EBITDA Margin	26.8%	24.6%	27.3%	16.6%	21.3%	24.7%	24.2%	22.9%	·	·
ROA	7.5%	5.8%	3.5%	0.96%	2.7%	6.6%	7.8%	5.9%	·	·
ROE	11.3%	9.5%	6.1%	1.7%	4.7%	10.9%	12.4%	9.5%	·	·
ROIC	9.1%	7.7%	6.9%	2.0%	3.4%	7.6%	9.7%	7.8%	·	·

Liquidity & Solvency 5

Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	2.1	2.0	3.1	2.3	2.0	2.1	2.4	2.3	·	·
Quick Ratio	1.0	1.0	1.1	1.1	0.9	1.4	1.8	1.7	·	·
Debt / Equity	0.3	0.3	0.5	0.5	0.5	0.4	0.3	0.4	·	·
LT Debt / Equity	0.3	0.3	0.5	0.5	0.5	0.4	0.3	0.4	·	·
Interest Coverage	·	·	5.8	2.5	4.8	14.7	13.3	9.1	·	·

Efficiency 3

Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover	0.6	0.5	0.5	0.4	0.5	0.5	0.6	0.5	·	·
Inventory Turnover	5.5	4.9	4.6	4.4	5.8	6.1	7.5	7.8	·	·
Receivables Turnover	5.6	5.3	5.5	5.7	6.5	5.2	5.3	5.1	·	·

Per Share 7

Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$73.45	$67.18	$63.73	$61.62	$65.28	$45.47	$39.96	$37.60	·	·
Revenue / Share	$60.14	$55.11	$51.72	$49.46	$46.63	$36.18	$35.39	$32.55	·	·
Cash Flow / Share	$13.59	$11.59	$9.80	$7.55	$6.96	$8.03	$6.90	$6.31	·	·
Cash / Share	·	·	·	·	·	$2.58	$3.76	$2.61	·	·
Dividend / Share	$2.46	$2.23	$2.03	$1.84	$1.69	$1.57	$1.45	$1.33	$1.21	$1.09
Dividend Paid / Share	$2.46	$2.23	$2.03	$1.84	$1.69	$1.57	$1.45	$1.33	$1.21	$1.09
EPS (TTM)	$7.93	$6.20	$3.81	$1.07	$2.48	$4.63	$4.76	$3.55	·	·

Growth Rates 10

Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	8.7%	6.2%	13.3%	7.4%	35.9%	·	·	·	·	·
Revenue CAGR 3Y	9.4%	8.9%	18.2%	·	·	·	·	·	·	·
Revenue CAGR 5Y	13.8%	·	·	·	·	·	·	·	·	·
EPS YoY	27.9%	62.7%	256.1%	-56.9%	-46.4%	·	·	·	·	·
EPS CAGR 3Y	95.0%	35.7%	-6.3%	·	·	·	·	·	·	·
EPS CAGR 5Y	11.4%	·	·	·	·	·	·	·	·	·
Net Income YoY	27.3%	62.5%	253.4%	-56.1%	-38.6%	·	·	·	·	·
Net Income CAGR 3Y	94.1%	36.1%	-1.6%	·	·	·	·	·	·	·
Net Income CAGR 5Y	14.5%	·	·	·	·	·	·	·	·	·
Dividends Paid CAGR 5Y	12.6%	·	·	·	·	·	·	·	·	·

Valuation (TTM) 17

Metric	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$5.94B	$5.46B	$5.14B	$4.54B	$4.22B	$3.11B	$3.03B	$2.78B	·	·
Net Income TTM	$782M	$615M	$378M	$107M	$244M	$397M	$408M	$304M	·	·
Market Cap	$21.63B	$22.28B	$22.23B	$18.87B	$24.19B	$16.26B	$11.89B	$10.82B	·	·
Enterprise Value	·	·	·	·	·	$17.69B	$12.72B	$11.78B	·	·
P/E	27.9	36.6	59.0	178.8	97.5	41.1	29.4	36.1	·	·
P/S	3.6	4.1	4.3	4.2	5.7	5.2	3.9	3.9	·	·
P/B	3.0	3.4	3.5	3.1	3.7	4.2	3.5	3.4	·	·
P / Tangible Book	15.8	34.1	198.2	155.6	·	·	·	·	·	·
P / Cash Flow	16.1	19.4	22.8	24.9	35.3	23.6	20.1	20.1	·	·
P / FCF	22.2	28.6	36.3	47.8	60.9	36.1	31.6	30.9	·	·
EV / EBITDA	·	·	·	·	·	23.0	17.3	18.5	·	·
EV / FCF	·	·	·	·	·	39.3	33.8	33.7	·	·
EV / Revenue	·	·	·	·	·	5.7	4.2	4.2	·	·
Dividend Yield	1.1%	0.99%	0.90%	0.97%	0.67%	0.82%	1.0%	1.0%	·	·
Earnings Yield	3.6%	2.7%	1.7%	0.56%	1.0%	2.4%	3.4%	2.8%	·	·
Payout Ratio	30.9%	35.8%	53.0%	171.4%	66.9%	33.7%	30.2%	37.0%	·	·
Annual Payout	$242M	$220M	$201M	$183M	$163M	$134M	$123M	$113M	·	·

Income Statement 17

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Revenue	$1.49B	$1.59B	$1.50B	$1.46B	$1.39B	$1.48B	$1.37B	$1.33B	$1.28B	$1.42B	$1.30B	$1.24B	$1.18B	$963M	$1.11B	$1.09B
Cost of Revenue	$809M	$891M	$841M	$814M	$763M	$839M	$760M	$750M	$707M	$836M	$738M	$692M	$654M	$554M	$634M	$609M
Gross Profit	$684M	$697M	$656M	$646M	$628M	$641M	$610M	$579M	$572M	$583M	$560M	$546M	$529M	$409M	$478M	$482M
R&D Expense	$29M	$29M	$30M	$28M	$26M	$28M	$27M	$27M	$26M	$27M	$25M	$26M	$25M	$23M	$26M	$25M
SG&A Expense	$370M	$352M	$352M	$350M	$354M	$334M	$336M	$329M	$336M	$309M	$308M	$328M	$307M	$128M	$305M	$323M
Operating Expenses	$398M	$380M	$382M	$380M	$382M	$425M	$365M	$359M	$387M	$363M	$334M	$355M	$331M	$-339M	$331M	$839M
Operating Income	$286M	$317M	$273M	$266M	$246M	$216M	$245M	$220M	$186M	$220M	$226M	$192M	$198M	$748M	$191M	$-306M
Interest Expense	·	·	·	·	·	·	·	·	$30M	·	$39M	$37M	$32M	·	$29M	$26M
Other Non-op	$3M	$3M	$3M	$2M	$2M	$4M	$2M	$1M	$1M	$6M	$2M	$1M	$1M	$321.0K	$-2M	$-524.0K
Pretax Income	$274M	$304M	$258M	$253M	$232M	$197M	$229M	$195M	$175M	$191M	$190M	$156M	$167M	$718M	$172M	$159M
Income Tax	$72M	$84M	$64M	$61M	$54M	$50M	$55M	$44M	$35M	$37M	$41M	$35M	$36M	$81M	$41M	$35M
Net Income	$200M	$220M	$193M	$192M	$177M	$146M	$174M	$150M	$145M	$-1M	$141M	$115M	$124M	$187M	$124M	$-315M
EPS (Basic)	·	$2.26	$1.96	$1.95	$1.80	$1.49	$1.76	$1.52	$1.47	$-0.01	$1.42	$1.17	$1.25	$1.87	$1.24	$-3.15
EPS (Diluted)	·	$2.24	$1.96	$1.94	$1.79	$1.48	$1.75	$1.51	$1.46	$-0.02	$1.42	$1.16	$1.25	$1.88	$1.24	$-3.15
Shares (Basic)	97,600,000	·	98,200,000	98,400,000	98,400,000	·	98,500,000	98,700,000	98,900,000	·	98,802,000	98,785,000	98,708,000	·	99,716,000	99,969,000
Shares (Diluted)	97,900,000	·	98,600,000	98,800,000	98,800,000	·	98,900,000	99,200,000	99,400,000	·	99,354,000	99,406,000	99,239,000	·	100,166,000	99,969,000
EBITDA	$410M	·	$273M	$266M	$365M	·	$245M	$220M	$298M	·	$216M	$186M	$327M	·	$191M	$-306M

Balance Sheet 26

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Cash & Equivalents	$482M	·	$424M	$319M	$280M	·	$155M	$172M	$198M	·	$196M	$214M	$209M	·	$259M	$258M
Receivables	$1.01B	$1.09B	$991M	$947M	$947M	$1.04B	$915M	$923M	$893M	$1.01B	$964M	$940M	$888M	·	$823M	$780M
Inventory	$712M	$632M	$674M	$658M	$641M	$581M	$650M	$689M	$699M	$675M	$856M	$821M	$769M	·	$694M	$645M
Current Assets	$2.45B	$2.39B	$2.29B	$2.11B	$2.06B	$2.00B	$1.90B	$1.94B	$1.94B	$2.87B	$2.22B	$2.17B	$2.03B	·	$1.98B	$1.89B
PP&E (Net)	$2.17B	$2.16B	$2.13B	$2.09B	$2.05B	$1.96B	$1.92B	$1.93B	$1.83B	$1.77B	$1.84B	$1.74B	$1.73B	·	$1.67B	$1.57B
PP&E (Gross)	$4.17B	$4.11B	$4.05B	$3.96B	$3.87B	$3.69B	$3.61B	$3.60B	$3.44B	$3.34B	$3.41B	$3.25B	$3.20B	·	$3.06B	$2.90B
Accum. Depreciation	$2.00B	$1.94B	$1.92B	$1.86B	$1.82B	$1.73B	$1.68B	$1.67B	$1.61B	$1.57B	$1.56B	$1.51B	$1.48B	·	$1.38B	$1.32B
Goodwill	$4.19B	$4.19B	$4.23B	$4.22B	$4.22B	$4.10B	$4.04B	$4.15B	$4.06B	$4.07B	$4.11B	$4.04B	$3.89B	$3.88B	$3.85B	$3.71B
Intangibles	$1.56B	$1.62B	$1.69B	$1.75B	$1.82B	$1.85B	$1.92B	$2.00B	$2.05B	$2.12B	$2.99B	$3.06B	$2.87B	·	$3.03B	$3.08B
Other Non-current Assets	$215M	$211M	$94M	$88M	$89M	$83M	$68M	$60M	$63M	$66M	$77M	$73M	$80M	·	$80M	$72M
Total Assets	$10.74B	$10.74B	$10.59B	$10.41B	$10.40B	$10.15B	$10.01B	$10.24B	$10.11B	$11.06B	$11.44B	$11.28B	$10.78B	·	$10.80B	$10.49B
Accounts Payable	$344M	$339M	$285M	$309M	$301M	$281M	$238M	$235M	$232M	$252M	$277M	$294M	$261M	·	$242M	$233M
Accrued Liabilities	$420M	$402M	$405M	$360M	$371M	$368M	$335M	$307M	$287M	$320M	$318M	$307M	$333M	·	$303M	$304M
Short-term Debt	$243M	$119M	$0	$0	$0	$125M	$125M	$80M	$80M	$86M	$78M	$71M	$63M	·	$60M	$151M
Current Liabilities	$1.28B	$1.15B	$922M	$889M	$927M	$1.02B	$891M	$805M	$834M	$931M	$914M	$873M	$887M	·	$796M	$873M
Capital Leases	·	$120M	·	·	·	$125M	·	·	·	$146M	·	·	·	·	·	·
Other Non-current Liabilities	$75M	$72M	$67M	$64M	$64M	$62M	$73M	$74M	$72M	$72M	$78M	$77M	$77M	·	$73M	$76M
Total Liabilities	$3.51B	$3.54B	$3.42B	$3.39B	$3.44B	$3.53B	$3.58B	$3.63B	$3.74B	$4.75B	$5.01B	$5.09B	$4.61B	·	$4.75B	$4.68B
Long-term Debt	$1.65B	$1.81B	$1.90B	$1.90B	$1.90B	$1.92B	$2.04B	$2.16B	$2.24B	$3.12B	$3.23B	$3.37B	$2.86B	·	$3.00B	$2.87B
Total Debt	$1.89B	·	$1.90B	$1.90B	$1.90B	·	$2.16B	$2.24B	$2.32B	·	$3.31B	$3.44B	$2.92B	·	$3.06B	$3.02B
Common Stock	$4.18B	$4.28B	$4.34B	$4.36B	$4.43B	$4.42B	$4.40B	$4.49B	$4.50B	$4.54B	$4.53B	$4.52B	$4.50B	·	$4.63B	$4.71B
Retained Earnings	$3.15B	$3.02B	$2.86B	$2.73B	$2.60B	$2.48B	$2.39B	$2.27B	$2.18B	$2.09B	$2.13B	$2.05B	$1.98B	·	$1.77B	$1.70B
AOCI	$-127M	$-113M	$-43M	$-76M	$-70M	$-292M	$-374M	$-166M	$-323M	$-329M	$-253M	$-387M	$-311M	$-321M	$-364M	$-598M
Stockholders' Equity	$7.21B	$7.18B	$7.15B	$7.01B	$6.96B	$6.60B	$6.42B	$6.59B	$6.35B	$6.30B	$6.42B	$6.18B	$6.17B	·	$6.04B	$5.80B
Liabilities + Equity	$10.74B	$10.74B	$10.59B	$10.41B	$10.40B	$10.15B	$10.01B	$10.24B	$10.11B	$11.06B	$11.44B	$11.28B	$10.78B	·	$10.80B	$10.49B
Shares Outstanding	97,500,000	97,800,000	98,100,000	98,100,000	98,500,000	98,300,000	98,245,000	98,708,000	98,799,000	98,900,000	98,808,000	98,789,000	98,781,000	98,629,000	99,401,000	99,868,000

Cash Flow 15

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
D&A	$124M	$123M	$122M	$122M	$119M	$122M	$126M	$115M	$113M	$134M	$141M	$152M	$138M	$142M	$138M	$134M
Stock-based Comp	$13M	$13M	$16M	$21M	$12M	$10M	$15M	$21M	$12M	$9M	$15M	$21M	$12M	$9M	$9M	$12M
Deferred Tax	$600.0K	$-17M	$-100.0K	$-100.0K	$0	$-53M	$-2M	$21.0K	$-22M	$-131M	$808.0K	$-869.0K	$-445.0K	$-123M	$101.0K	$-68M
Restructuring	·	$300.0K	$100.0K	$1M	$2M	$29M	$2M	$3M	$28M	$44M	$6.0K	$-23.0K	$19.0K	$359.0K	$38.0K	$62.0K
Other Non-cash	$30M	·	·	·	$111M	·	·	·	$56M	·	·	·	$9M	·	·	·
Operating Cash Flow	$367M	$335M	$298M	$288M	$420M	$261M	$333M	$251M	$304M	$255M	$291M	$146M	$281M	$216M	$206M	$104M
CapEx	$88M	$90M	$99M	$86M	$94M	$71M	$89M	$102M	$108M	$91M	$119M	$83M	$67M	$71M	$92M	$83M
Investing Cash Flow	$-108M	$-217M	$-98M	$-88M	$-108M	$-70M	$-124M	$-105M	$688M	$-96M	$-119M	$-606M	$-67M	$-78M	$-98M	$-98M
Stock Repurchased	$116M	$74M	$50M	$100M	$11M	$200.0K	$100M	$46M	$64M	$359.0K	$2M	$489.0K	$9M	$155M	$84M	$45M
Net Stock Activity	$-116M	·	·	·	$-11M	·	·	$-46M	$-64M	·	$-2M	$-489.0K	$-9M	·	$-84M	$-45M
Dividends Paid	$61M	$62M	$62M	$62M	$56M	$56M	$56M	$56M	$51M	$51M	$51M	$51M	$46M	$47M	$47M	$47M
Financing Cash Flow	$-214M	$-98M	$-98M	$-159M	$-213M	$-178M	$-214M	$-181M	$-999M	$-144M	$-198M	$470M	$-214M	$-192M	$-120M	$-45M
Net Change in Cash	$43M	$16M	$104M	$40M	$108M	$16M	$-17M	$-26M	$-9M	$11M	$-18M	$5M	$257.0K	$-51M	$1M	$-58M
Free Cash Flow	$280M	·	·	·	$326M	·	·	·	$196M	·	·	·	$215M	·	·	·
Levered FCF	·	·	·	·	·	·	·	·	$171M	·	·	·	$189M	·	·	·

Profitability 8

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Gross Margin	45.8%	·	43.8%	44.2%	45.1%	·	44.5%	43.5%	44.7%	·	43.2%	44.2%	44.6%	·	42.9%	44.3%
Operating Margin	19.1%	·	18.3%	18.2%	17.7%	·	17.9%	16.5%	14.5%	·	15.5%	13.9%	14.7%	·	15.7%	-25.5%
Net Margin	13.4%	·	12.9%	13.1%	12.8%	·	12.7%	11.3%	11.4%	·	10.1%	8.6%	9.6%	·	10.2%	-26.3%
Pretax Margin	18.3%	·	17.2%	17.3%	16.7%	·	16.7%	14.7%	13.7%	·	12.8%	11.2%	12.3%	·	13.2%	-27.7%
EBITDA Margin	27.4%	·	18.3%	18.2%	26.3%	·	17.9%	16.5%	23.3%	·	15.5%	13.9%	25.4%	·	15.7%	-25.5%
ROA	1.9%	·	1.9%	1.9%	1.7%	·	1.6%	1.4%	1.4%	·	1.3%	1.1%	1.1%	·	1.1%	-2.8%
ROE	2.8%	·	2.8%	2.8%	2.7%	·	2.7%	2.4%	2.3%	·	2.3%	1.9%	2.0%	·	2.0%	-5.1%
ROIC	2.3%	·	2.3%	2.3%	2.1%	·	2.2%	1.9%	1.7%	·	1.8%	1.5%	1.6%	·	1.6%	-3.3%

Liquidity & Solvency 5

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Current Ratio	1.9	·	2.5	2.4	2.2	·	2.1	2.4	2.3	·	2.4	2.5	2.3	·	2.5	2.2
Quick Ratio	1.2	·	1.5	1.4	1.3	·	1.2	1.4	1.3	·	1.3	1.3	1.2	·	1.4	1.2
Debt / Equity	0.3	·	0.3	0.3	0.3	·	0.3	0.3	0.4	·	0.5	0.6	0.5	·	0.5	0.5
LT Debt / Equity	0.2	·	0.3	0.3	0.3	·	0.3	0.3	0.4	·	0.5	0.5	0.5	·	0.5	0.5
Interest Coverage	·	·	·	·	·	·	·	·	6.1	·	5.5	5.0	5.8	·	6.7	-11.7

Efficiency 3

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Asset Turnover	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1
Inventory Turnover	1.2	·	1.3	1.2	1.1	·	1.0	1.0	1.0	·	1.0	1.0	1.0	·	1.1	1.1
Receivables Turnover	1.5	·	1.6	1.6	1.5	·	1.5	1.4	1.4	·	1.6	1.6	1.6	·	1.5	1.6

Per Share 7

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Book Value / Share	$73.91	·	$72.93	$71.45	$70.63	·	$65.31	$66.80	$64.32	·	$64.93	$62.54	$62.44	·	$60.75	$58.10
Revenue / Share	$15.25	·	$15.17	$14.78	$14.08	·	$13.85	$13.40	$12.88	·	$14.05	$13.50	$12.94	·	$12.14	·
Cash Flow / Share	$3.75	·	·	·	$4.25	·	·	·	$3.06	·	·	·	$2.83	·	·	·
Cash / Share	$4.95	·	$4.32	$3.25	$2.84	·	$1.58	$1.74	$2.01	·	$1.98	$2.16	$2.11	·	$2.61	$2.59
Dividend / Share	$0.63	$0.63	$0.63	$0.63	$0.57	$0.57	$0.57	$0.57	$0.52	$0.52	$0.52	$0.52	$0.47	$0.47	$0.47	$0.47
Dividend Paid / Share	$0.63	$0.63	$0.63	$0.63	$0.57	$0.62	$0.57	$0.52	$0.52	$0.52	$0.52	$0.52	$0.47	$0.47	$0.47	$0.47
EPS (TTM)	$7.93	·	$7.17	$6.96	$6.53	·	$4.70	$4.37	$4.02	·	$5.71	$5.53	$1.22	·	$-0.20	$-0.02

Valuation (TTM) 14

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Revenue TTM	$6.04B	·	$5.83B	$5.70B	$5.57B	·	$5.40B	$5.33B	$5.23B	·	$4.68B	$4.50B	$4.35B	·	$4.10B	$4.20B
Net Income TTM	$805M	·	$708M	$688M	$647M	·	$467M	$435M	$400M	·	$567M	$550M	$119M	·	$-28M	$-8M
Market Cap	$20.53B	·	$24.87B	$24.27B	$23.66B	·	$20.20B	$23.94B	$21.69B	·	$21.72B	$21.68B	$22.22B	·	$18.36B	$16.61B
Enterprise Value	$21.94B	·	$26.35B	$25.85B	$25.29B	·	$22.20B	$26.00B	$23.81B	·	$24.84B	$24.90B	$24.94B	·	$21.16B	$19.37B
P/E	26.6	·	35.4	35.6	36.8	·	43.7	55.5	54.6	·	38.5	39.7	184.4	·	-923.5	-8314.0
P/S	3.4	·	4.3	4.3	4.2	·	3.7	4.5	4.1	·	4.6	4.8	5.1	·	4.5	4.0
P/B	2.8	·	3.5	3.5	3.4	·	3.1	3.6	3.4	·	3.4	3.5	3.6	·	3.0	2.9
P / Tangible Book	14.1	·	20.2	23.2	25.8	·	45.0	54.6	87.2	·	·	·	·	·	·	·
P / Cash Flow	55.9	·	·	·	56.3	·	·	·	71.4	·	·	·	79.1	·	·	·
EV / Revenue	3.6	·	4.5	4.5	4.5	·	4.1	4.9	4.5	·	5.3	5.5	5.7	·	5.2	4.6
Dividend Yield	1.2%	·	0.95%	0.95%	0.95%	·	1.1%	0.88%	0.95%	·	0.90%	0.88%	0.84%	·	0.98%	1.1%
Earnings Yield	3.8%	·	2.8%	2.8%	2.7%	·	2.3%	1.8%	1.8%	·	2.6%	2.5%	0.54%	·	-0.11%	-0.01%
Payout Ratio	30.7%	·	·	·	31.7%	·	·	·	35.4%	·	·	·	37.6%	·	·	·
Annual Payout	$247M	·	$236M	$230M	$225M	·	$215M	$210M	$206M	·	$196M	$191M	$187M	·	$180M	$176M

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Revenue	$5.94B	$5.46B	$5.14B	$4.54B	$4.22B
Gross Margin %	44.2%	44.0%	43.2%	43.6%	44.0%
Operating Margin %	18.6%	15.9%	16.3%	5.4%	9.3%
Net Income	$782M	$615M	$378M	$107M	$244M
Diluted EPS	$7.93	$6.20	$3.81	$1.07	$2.48

Metric	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Debt / Equity	0.3	0.3	0.5	0.5	0.5
Current Ratio	2.1	2.0	3.1	2.3	2.0
Quick Ratio	1.0	1.0	1.1	1.1	0.9

Metric	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Free Cash Flow	$972M	$778M	$613M	$395M	$397M

Institutional owners (13F) 880 filers · $22.6B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 880

Value held $22.6B

New positions 99

Exited positions 99

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
99 (-4 vs prior Q)	99 (-23 vs prior Q)	293 (+28 vs prior Q)	306 (-34 vs prior Q)	+844K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
VANGUARD GROUP INC	$3,114,882,353	12,286,535	13.80%	Shares
BlackRock, Inc.	$1,857,414,656	8,820,889	8.23%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$1,349,102,196	6,406,906	5.98%	Shares
STATE STREET CORP	$1,068,232,039	5,072,818	4.73%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$1,053,260,612	5,001,950	4.67%	Shares
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	$850,363,483	3,801,077	3.77%	Shares
MORGAN STANLEY	$831,766,442	3,950,067	3.69%	Shares
WELLINGTON MANAGEMENT GROUP LLP	$737,605,022	3,502,897	3.27%	Shares
Orbis Allan Gray Ltd	$563,845,394	2,677,710	2.50%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$548,620,258	2,615,842	2.43%	Shares
GENERATION INVESTMENT MANAGEMENT LLP	$480,246,578	2,280,698	2.13%	Shares
Mitsubishi UFJ Asset Management Co., Ltd.	$463,300,325	2,200,220	2.05%	Shares
JANUS HENDERSON GROUP PLC	$411,994,872	1,863,139	1.83%	Shares
Select Equity Group, L.P.	$398,955,608	1,894,646	1.77%	Shares
Invesco Ltd.	$380,328,852	1,806,187	1.69%	Shares
Boston Partners	$315,497,209	1,498,334	1.40%	Shares
GOLDMAN SACHS GROUP INC	$287,037,463	1,363,145	1.27%	Shares
AQR CAPITAL MANAGEMENT LLC	$285,844,205	1,377,297	1.27%	Shares
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	$277,186,897	1,253,502	1.23%	Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$256,445,622	1,217,864	1.14%	Shares
DIMENSIONAL FUND ADVISORS LP	$252,635,989	1,199,619	1.12%	Shares
NORGES BANK	$251,035,869	1,192,173	1.11%	Shares
NORTHERN TRUST CORP	$194,908,435	925,623	0.86%	Shares
PRINCIPAL FINANCIAL GROUP INC	$188,588,689	895,576	0.84%	Shares
BANK OF AMERICA CORP /DE/	$175,849,376	835,111	0.78%	Shares
Legal & General Group Plc	$154,205,042	732,322	0.68%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$140,372,911	666,633	0.62%	Shares
Findlay Park Partners LLP	$138,494,626	657,713	0.61%	Shares
LONDON CO OF VIRGINIA	$135,103,429	641,604	0.60%	Shares
RAYMOND JAMES FINANCIAL INC	$127,005,820	603,153	0.56%	Shares
VANGUARD FIDUCIARY TRUST CO	$115,966,163	550,725	0.51%	Shares
ALLIANCEBERNSTEIN L.P.	$112,852,811	510,346	0.50%	Shares
DEUTSCHE BANK AG\	$112,363,310	533,615	0.50%	Shares
Amundi	$108,100,953	513,373	0.48%	Shares
D. E. Shaw & Co., Inc.	$107,308,578	509,610	0.48%	Shares
Bank of New York Mellon Corp	$106,001,338	503,402	0.47%	Shares
JPMORGAN CHASE & CO	$104,490,709	490,014	0.46%	Shares
LOCUST WOOD CAPITAL ADVISERS, LLC	$95,991,742	455,866	0.43%	Shares
ROYAL LONDON ASSET MANAGEMENT LTD	$89,099,538	423,135	0.39%	Shares
CITADEL ADVISORS LLC	$85,126,292	404,266	0.38%	Shares
UBS Group AG	$83,596,501	397,001	0.37%	Shares
Nuveen, LLC	$80,563,873	382,600	0.36%	Shares
Sustainable Growth Advisers, LP	$79,013,655	375,237	0.35%	Shares
WORLDQUANT MILLENNIUM ADVISORS LLC	$78,455,434	372,586	0.35%	Shares
Fenimore Asset Management Inc	$74,796,972	355,212	0.33%	Shares
Williams Jones Wealth Management, LLC.	$70,114,973	332,977	0.31%	Shares
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$66,103,000	313,924	0.29%	Shares
Life Cycle Investment Partners Ltd	$63,595,720	302,017	0.28%	Shares
Boston Trust Walden Corp	$63,265,756	300,450	0.28%	Shares
Gotham Asset Management, LLC	$62,307,242	295,898	0.28%	Shares

Show all 880 institutional owners →

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
STERIS plc, Solar New US Holding Co, LLC, Crystal Merger Sub 1, LLC	Jan. 22, 2021	·	Initial filing	M&A / sale	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 31 insiders · 16 officers · 17 directors

19

Insider	Role	Last activity	Shares owned	Sells 12m	Net 12m
Daniel A Carestio	President and CEO	June 5, 2026 S	63,647	3	$-985,248
Walter M Rosebrough Jr	President & CEO	Nov. 9, 2020 S	51,405	0	$0
Karen L Burton	Sr. Vice Pres., CFO	June 4, 2026 F	13,184	0	$0
Michael J Tokich	Sr. Vice Pres., CFO	June 4, 2025 F	43,891	0	$0
John Adam Zangerle	Sr. VP, Gen Counsel, and Sec.	June 15, 2026 S	35,259	2	$-4,274,068
Kenneth E Kohler	SVP & GM, AST	June 4, 2026 F	11,332	0	$0
Julia Madsen	Sr. VP and GM, Life Sciences	June 4, 2026 F	12,257	2	$-1,312,096
Mary Clare Fraser	SVP & Chief HRO	June 4, 2026 F	13,716	0	$0
Renato Tamaro	V.P. & Corporate Treasurer	June 4, 2026 F	6,194	3	$-1,297,039
Lindsey Mcgowan	VP, Chf. Comp. & Quality Offc.	June 2, 2026 A	5,656	0	$0
Cary L Majors	SVP and President, Healthcare	June 2, 2026 A	17,338	0	$0
Andrew Xilas	SVP and GM, Dental	May 31, 2024 F	6,347	0	$0
Kathleen Bardwell	Sr.V. P. & C.C.O.	June 28, 2019 M	17,428	0	$0
Adrian Vincent Coward	Sr. V P, Healthcare Spec Serv	May 31, 2019 A	25,119	0	$0
Gulam Amjad Khan	Sr. V.P., Procedural Solutions	May 31, 2019 A	14,685	0	$0
Michiel Dezwaan	V.P., Human Resources & CHRO	March 28, 2019 A	30	0	$0
Mohsen Sohi	Director	Aug. 12, 2026 M	24,305	1	$-956,795
Pierre Boulud	Director	Aug. 10, 2026 A	·	0	$0
Louis Shapiro	Director	Aug. 10, 2026 A	·	0	$0
Esther M. Alegria	Director	Aug. 10, 2026 A	·	0	$0
Nirav R Shah	Director	Aug. 10, 2026 A	292	0	$0
Paul Edward Martin	Director	Aug. 10, 2026 A	·	0	$0
Christopher S Holland	Director	Aug. 10, 2026 A	582	0	$0
Cynthia L Feldmann	Director	Aug. 10, 2026 A	705	1	$-734,877
Richard C Breeden	Director	June 2, 2026 M	38,964	1	$-310,284
Richard Martin Steeves	Director	Aug. 8, 2024 A	0	0	$0
Jacqueline B Kosecoff	Director	Aug. 8, 2024 A	0	0	$0
David B Lewis	Director	July 21, 2021 M	8,245	0	$0
Loyal W Wilson	Director	June 4, 2019 M	24,000	0	$0
Michael B Wood	Director	May 16, 2019 S	16,631	0	$0
Duncan K Nichol	Director	March 28, 2019 A	·	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 107 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
IHI · iShares Trust	3.14%	468,870 SH	Sept. 11, 2026	Daily
POWA · Invesco Exchange-Traded Self-Indexe…	1.88%	14,818 SH	Oct. 2, 2026	Daily
NUMV · Nushares ETF Trust	1.62%	31,484 NS	July 31, 2026	N-PORT
RSPH · Invesco Exchange-Traded Fund Trust	1.61%	66,867 SH	Oct. 2, 2026	Daily
NUDV · Nushares ETF Trust	0.95%	2,081 NS	July 31, 2026	N-PORT
SUSA · iShares Trust	0.63%	119,264 SH	Sept. 11, 2026	Daily
EVUS · iShares Trust	0.49%	8,778 SH	Sept. 11, 2026	Daily
NULV · Nushares ETF Trust	0.40%	38,341 NS	July 31, 2026	N-PORT
IYH · iShares Trust	0.34%	57,333 SH	Sept. 11, 2026	Daily
VFMV · VANGUARD WELLINGTON FUND	0.33%	6,491 SH	Aug. 19, 2026	Daily
ESGU · iShares Trust	0.32%	272,491 SH	Sept. 11, 2026	Daily
VHT · VANGUARD WORLD FUND	0.30%	294,875 SH	Aug. 19, 2026	Daily
IXJ · iShares Trust	0.26%	51,423 SH	Sept. 11, 2026	Daily
CURE · Direxion Shares ETF Trust	0.26%	1,930 NS	July 31, 2026	N-PORT
VOT · VANGUARD INDEX FUNDS	0.23%	375,677 SH	Aug. 19, 2026	Daily
ESLG · Strategy Shares	0.22%	225 NS	July 31, 2026	N-PORT
IWS · iShares Trust	0.20%	146,233 SH	Sept. 11, 2026	Daily
VO · VANGUARD INDEX FUNDS	0.20%	2,125,301 SH	Aug. 19, 2026	Daily
RSP · Invesco Exchange-Traded Fund Trust	0.20%	907,382 SH	Oct. 2, 2026	Daily
SIZE · iShares Trust	0.19%	3,854 SH	Sept. 11, 2026	Daily
EUSA · iShares, Inc.	0.18%	16,470 SH	Sept. 11, 2026	Daily
VOE · VANGUARD INDEX FUNDS	0.18%	315,003 SH	Aug. 19, 2026	Daily
SPHQ · Invesco Exchange-Traded Fund Trust	0.18%	159,004 SH	Oct. 2, 2026	Daily
PDN · Invesco Exchange-Traded Fund Trust …	0.17%	69,786 SH	Oct. 2, 2026	Daily
ESUM · Strategy Shares	0.17%	1,373 NS	July 31, 2026	N-PORT
IMCV · iShares Trust	0.17%	9,269 SH	Sept. 11, 2026	Daily
IDHQ · Invesco Exchange-Traded Fund Trust …	0.16%	207,104 SH	Oct. 2, 2026	Daily
DFLV · Dimensional ETF Trust	0.16%	47,873 NS	July 31, 2026	N-PORT
ESMV · iShares Trust	0.16%	59 SH	Sept. 11, 2026	Daily
IWR · iShares Trust	0.15%	400,582 SH	Sept. 11, 2026	Daily
ESLV · Strategy Shares	0.15%	93 NS	July 31, 2026	N-PORT
IMCB · iShares Trust	0.15%	11,557 SH	Sept. 11, 2026	Daily
IMCG · iShares Trust	0.12%	23,208 SH	Sept. 11, 2026	Daily
XOEF · iShares Trust	0.12%	122 SH	Sept. 11, 2026	Daily
CATH · Global X Funds	0.11%	6,055 NS	July 31, 2026	N-PORT
DFUV · Dimensional ETF Trust	0.10%	67,539 NS	July 31, 2026	N-PORT
EQAL · Invesco Exchange-Traded Fund Trust …	0.09%	3,558 SH	Oct. 2, 2026	Daily
PFIG · Invesco Exchange-Traded Fund Trust …	0.09%	130,000	Oct. 2, 2026	Daily
VIG · VANGUARD SPECIALIZED FUNDS	0.09%	554,067 SH	Aug. 19, 2026	Daily
DXUV · Dimensional ETF Trust	0.09%	2,140 NS	July 31, 2026	N-PORT
VTV · VANGUARD INDEX FUNDS	0.08%	931,689 SH	Aug. 19, 2026	Daily
PFM · Invesco Exchange-Traded Fund Trust	0.08%	2,780 SH	Oct. 2, 2026	Daily
DCOR · Dimensional ETF Trust	0.07%	10,863 NS	July 31, 2026	N-PORT
DFAC · Dimensional ETF Trust	0.07%	154,755 NS	July 31, 2026	N-PORT
OMFL · Invesco Exchange-Traded Self-Indexe…	0.07%	16,155 SH	Oct. 2, 2026	Daily
CHRI · Global X Funds	0.07%	24 NS	July 31, 2026	N-PORT
SUSL · iShares Trust	0.06%	3,429 SH	Sept. 11, 2026	Daily
IMFL · Invesco Exchange-Traded Self-Indexe…	0.06%	75,373 SH	Oct. 2, 2026	Daily
VONV · VANGUARD SCOTTSDALE FUNDS	0.06%	59,118 SH	Aug. 19, 2026	Daily
DSI · iShares Trust	0.06%	15,165 SH	Sept. 11, 2026	Daily
CRBN · iShares Trust	0.06%	3,088 SH	Sept. 11, 2026	Daily
IWD · iShares Trust	0.06%	217,252 SH	Sept. 11, 2026	Daily
DGRO · iShares Trust	0.05%	110,714 SH	Sept. 11, 2026	Daily
EGLE · Global X Funds	0.05%	5 NS	July 31, 2026	N-PORT
QVML · Invesco Exchange-Traded Fund Trust …	0.05%	4,010 SH	Oct. 2, 2026	Daily
DFAU · Dimensional ETF Trust	0.04%	23,890 NS	July 31, 2026	N-PORT
DFSU · Dimensional ETF Trust	0.04%	4,327 NS	July 31, 2026	N-PORT
IUS · Invesco Exchange-Traded Self-Indexe…	0.04%	1,998 SH	Oct. 2, 2026	Daily
TOPC · iShares Trust	0.04%	62 SH	Sept. 11, 2026	Daily
VOOV · VANGUARD ADMIRAL FUNDS	0.04%	11,347 SH	Aug. 19, 2026	Daily
ESGV · VANGUARD WORLD FUND	0.04%	22,125 SH	Aug. 19, 2026	Daily
XYLG · Global X Funds	0.04%	112 NS	July 31, 2026	N-PORT
XYLD · Global X Funds	0.04%	5,420 NS	July 31, 2026	N-PORT
XVV · iShares Trust	0.04%	1,132 SH	Sept. 11, 2026	Daily
VOTE · TCW ETF Trust	0.03%	1,670 NS	July 31, 2026	N-PORT
IVE · iShares Trust	0.03%	80,778 SH	Sept. 11, 2026	Daily
ILCV · iShares Trust	0.03%	2,187 SH	Sept. 11, 2026	Daily
PRF · Invesco Exchange-Traded Fund Trust	0.03%	15,958 SH	Oct. 2, 2026	Daily
XRMI · Global X Funds	0.03%	74 NS	July 31, 2026	N-PORT
DFUS · Dimensional ETF Trust	0.03%	30,498 NS	July 31, 2026	N-PORT
IUSV · iShares Trust	0.03%	42,821 SH	Sept. 11, 2026	Daily
SPUU · Direxion Shares ETF Trust	0.03%	370 NS	July 31, 2026	N-PORT
XCLR · Global X Funds	0.03%	5 NS	July 31, 2026	N-PORT
IVV · iShares Trust	0.03%	1,236,184 SH	Sept. 11, 2026	Daily
ILCB · iShares Trust	0.03%	1,913 SH	Sept. 11, 2026	Daily
PBP · Invesco Exchange-Traded Fund Trust	0.03%	583 SH	Oct. 2, 2026	Daily
PBUS · Invesco Exchange-Traded Fund Trust …	0.03%	16,872 SH	Oct. 2, 2026	Daily
RWL · Invesco Exchange-Traded Fund Trust …	0.03%	13,984 SH	Oct. 2, 2026	Daily
VOO · VANGUARD INDEX FUNDS	0.03%	2,548,531 SH	Aug. 19, 2026	Daily
VV · VANGUARD INDEX FUNDS	0.03%	114,510 SH	Aug. 19, 2026	Daily
VTI · VANGUARD INDEX FUNDS	0.03%	3,115,102 SH	Aug. 19, 2026	Daily
VOOG · VANGUARD ADMIRAL FUNDS	0.03%	36,417 SH	Aug. 19, 2026	Daily
VONE · VANGUARD SCOTTSDALE FUNDS	0.03%	16,114 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.03%	8,227 SH	Aug. 19, 2026	Daily
IYY · iShares Trust	0.03%	4,226 SH	Sept. 11, 2026	Daily
IWB · iShares Trust	0.03%	67,954 SH	Sept. 11, 2026	Daily
IVW · iShares Trust	0.03%	105,352 SH	Sept. 11, 2026	Daily
ITOT · iShares Trust	0.03%	128,261 SH	Sept. 11, 2026	Daily
IWV · iShares Trust	0.03%	26,980 SH	Sept. 11, 2026	Daily
XTR · Global X Funds	0.03%	6 NS	July 31, 2026	N-PORT
ILCG · iShares Trust	0.03%	4,117 SH	Sept. 10, 2026	Daily
HCMT · Direxion Shares ETF Trust	0.03%	683 NS	July 31, 2026	N-PORT
IUSG · iShares Trust	0.03%	42,749 SH	Sept. 11, 2026	Daily
PHDG · Invesco Actively Managed Exchange-T…	0.03%	78 SH	Oct. 2, 2026	Daily
SPXL · Direxion Shares ETF Trust	0.03%	7,670 NS	July 31, 2026	N-PORT
TOK · iShares Trust	0.02%	271 SH	Sept. 11, 2026	Daily
URTH · iShares, Inc.	0.02%	9,040 SH	Sept. 11, 2026	Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0.02%	83,634 SH	Aug. 19, 2026	Daily
ACWI · iShares Trust	0.02%	30,640 SH	Sept. 11, 2026	Daily
PZA · Invesco Exchange-Traded Fund Trust …	0.02%	795,000	Oct. 2, 2026	Daily
DFVX · Dimensional ETF Trust	0.00%	82 NS	July 31, 2026	N-PORT
BLV · VANGUARD BOND INDEX FUNDS	·	·	July 15, 2026	Daily
BND · VANGUARD BOND INDEX FUNDS	·	·	July 15, 2026	Daily
VCSH · VANGUARD SCOTTSDALE FUNDS	·	·	July 15, 2026	Daily
VCLT · VANGUARD SCOTTSDALE FUNDS	·	·	July 15, 2026	Daily
VTC · VANGUARD SCOTTSDALE FUNDS	·	·	July 30, 2026	Daily
BNDW · VANGUARD SCOTTSDALE FUNDS	·	·	July 14, 2026	Daily

STE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 16 analysts BUY

Median target $269.50 +29.2%

3 18.8% Strong Buy

8 50.0% Buy

5 31.2% Hold

0 0.0% Sell

0 0.0% Strong Sell

12-Month Price Target

8 analysts · 2026-10-02

Mean target $263.12 +26.2%

← Below all targets Current price $208.54

Low$232.00 Mean$263.12 High$280.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
STE	$21.63B	27.9	8.7%	13.2%	11.3%	44.2%
MDT	$106.66B	22.3	8.4%	13.2%	9.8%	·
TRIB	·	·	·	-85.4%	69.8%	38.6%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

STE STERIS plc (Ireland) Ordinary Shares